A pharmaceutical company based in Chatham, New Jersey, in US, has announced a research agreement with Kenya Medical Research ...
The DR Congo's capital Kinshasa needs more than double the mpox vaccines it currently has to immunise all the city's at-risk population, the virus response chief told AFP Wednesday.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback